Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease is a research paper published in Development (2025). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Additional Ventures
Grant: Innovation Award
National Heart, Lung, and Blood Institute
Grant: R01HL160665
NHLBI NIH HHS
Grant: U01HL157989
NHLBI NIH HHS
Grant: T32HL007284
UCSF Pediatric Heart Center
Grant: Catalyst Award
Additional Ventures
Grant: Catalyst to Independence Award
NHLBI NIH HHS
Grant: R01 HL155906
National Heart, Lung, and Blood Institute
Grant: R01HL162925
Additional Ventures
Indiana University
National Institutes of Health
Hellman Foundation
Hellman Family Fund
Saving tiny Hearts Society
UCSF Department of Anesthesia
California Institute for Regenerative Medicine
Roddenberry Foundation
UCSF Pediatric Heart Center
Younger Family Fund
NIH HHS
Saving Tiny Hearts Society
The Roddenberry Foundation
American Heart Association
MeSH Terms
Keywords